Tony Yu

Serum galectins as potential biomarkers of inflammatory bowel diseases

S. Dodd, S. Subramanian, Lu-Gang Yu, 2020, PloS one.

Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.

Valerie A Longo, Y. Fong, A. Szalay, 2015, Surgery.

Phase I/II clinical trial of a genetically modified and oncolytic vaccinia virus GL-ONC1 in patients with unresactable, chemotherapy-resistant peritoneal carcinomatosis.

F. Fend, A. Szalay, U. Lauer, 2013 .